M. Dror Michaelson, MD, PhD
Massachusetts General Hospital · Massachusetts General Hosptial
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name M. Dror Michaelson, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:29 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01885949 · Tivozanib + Enzalutamide in Adv Prostate CancerMassachusetts General Hospital · terminated · Prostate Cancer · principal investigator
- Ph3NCT01546987 · Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerRadiation Therapy Oncology Group · completed · Prostate Cancer · principal investigator
- Ph2NCT00556049 · Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaMassachusetts General Hospital · completed · Renal Cell Carcinoma, Neoplasm Metastases · principal investigator
- Ph2NCT00556205 · Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell CarcinomaMassachusetts General Hospital · withdrawn · Renal Cell Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.